Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 3/20 | 0.68 |
| ▸ | CTSS | P25774 | 6/20 | 0.64 |
| ▸ | CTSK | P43235 | 5/20 | 0.64 |
| ▸ | CTSB | P07858 | 2/20 | 0.64 |
| ▸ | CTSL | P07711 | 2/20 | 0.64 |
| ▸ | AKT1 | P31749 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | CTSG | P08311 | 1/20 | 0.54 |
| ▸ | CMA1 | P23946 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.54 |
| ▸ | REN | P00797 | 1/20 | 0.53 |
| ▸ | PPARA | Q07869 | 2/20 | 0.53 |
| ▸ | PPARG | P37231 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL495794 | 1.00 | ACE (0.68) | ACECTSSCTSKCTSBCTSL | |
| SCHEMBL495795 | 1.00 | ACE (0.68) | ACECTSSCTSKCTSBCTSL | |
| SCHEMBL17350165 | 0.96 | ACE (0.64) | ACECTSSCTSKCTSBCTSL | |
| SCHEMBL7450821 | 0.94 | ACE (0.61) | ACECTSSCTSKCTSBCTSL | |
| SCHEMBL13537626 | 0.90 | BCL2 (0.62) | ACECTSSCTSKCTSBCTSL | |
| SCHEMBL9754444 | 0.89 | REN (0.57) | ACECTSSCTSKCTSBCTSL | |
| SCHEMBL13086723 | 0.88 | ACE (0.55) | ACECTSSCTSKCTSBCTSL | |
| SCHEMBL6516027 | 0.88 | ACE (0.70) | ACECTSSCTSKCTSBCTSL | |
| SCHEMBL2603668 | 0.88 | ACE (0.70) | ACECTSSCTSKCTSBCTSL | |
| SCHEMBL17688687 | 0.88 | ACE (0.70) | ACECTSSCTSKCTSBCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111705043-B | Ketoreductase mutant with improved catalytic activity and application thereof | 南京朗恩生物科技有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-111662889-B | Ketoreductase mutant for producing darunavir intermediate | 南京朗恩生物科技有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-111690696-B | Method for preparing darunavir intermediate through biocatalysis | 南京朗恩生物科技有限公司 | 2021-12-31 | — | — | CN | claimed |
| EP-3409765-B1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | CODEXIS INC (US) | 2021-08-04 | — | — | EP | claimed |
| EP-3409765-A2 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | Codexis, Inc. (US) | 2018-12-05 | — | — | EP | claimed |
| EP-2446025-B1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | CODEXIS INC (US) | 2018-08-08 | — | — | EP | claimed |
| US-9404092-B2 | Ketoreductase-mediated stereoselective route to alpha chloroalcohols | CODEXIS, INC. (US) | 2016-08-02 | — | — | US | claimed |
| US-20160160187-A1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2016-06-09 | — | — | US | claimed |
| US-9029112-B2 | Ketoreductase-mediated stereoselective route to alpha chloroalcohols | CODEXIS, INC. (US) | 2015-05-12 | — | — | US | claimed |
| US-20140308732-A1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2014-10-16 | — | — | US | claimed |
| WO-2006127180-A1 | A PROCESS FOR PREPARING (2R,3S)-1,2-EPOXY-3-(PROTECTED)AMINO-4-SUBSTITUTED BUTANE AND INTERMEDIATES THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-11-30 | — | — | WO | claimed |
| CN-1128135-C | Process for reducing alpha-aminoketones | KANEKA CORP (JP) | 2003-11-19 | — | — | CN | claimed |
| EP-0969000-B1 | Process for reducing alpha-amino ketones | KANEKA CORP (JP) | 2002-12-04 | — | — | EP | claimed |
| EP-0779366-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 1-HALO-3-AMINO-4-PHENYL-2-BUTANOL DERIVATIVES | KANEKA CORP (JP) | 2002-04-03 | — | — | EP | claimed |
| US-6255522-B1 | USING AS REDUCING AGENT A REACTION PRODUCT OF ORGANOALUMINUM COMPOUND, SULFONATE AND ALCOHOL | KANEKA CORPORATION (JP) | 2001-07-03 | — | — | US | claimed |
| EP-0969000-A1 | PROCESS FOR REDUCING $G(a)-AMINO KETONES | KANEKA CORPORATION (JP) | 2000-01-05 | — | — | EP | claimed |
| CN-1228081-A | Process for reducing alpha-aminoketones | KANEKA CORP (JP) | 1999-09-08 | — | — | CN | claimed |
| CN-1178517-A | Process for reduction of carbonyl compounds | KANEKA CORP (JP) | 1998-04-08 | — | — | CN | claimed |
| US-5726047-A | Process for stereoselectively reducing 1-halo-3-amino-4-phenyl-2-butanone to the corresponding alcohol with microorganisms | KANEKA CORPORATION (JP) | 1998-03-10 | — | — | US | claimed |
| EP-0779366-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 1-HALO-3-AMINO-4-PHENYL-2-BUTANOL DERIVATIVES | KANEKA CORPORATION (JP) | 1997-06-18 | — | — | EP | claimed |